Idarucizumab as Antidote to Intracerebral Hemorrhage under Treatment with Dabigatran

Valentin Held,Philipp Eisele,Christoph Eschenfelder,Kristina Szabo

Idarucizumab as Antidote to Intracerebral Hemorrhage under Treatment with Dabigatran

2016

Valentin Held
Philipp Eisele
Christoph Eschenfelder
Kristina Szabo

Background and Purpose: Non-vitamin K anticoagulants (NOAC) such as dabigatran have become important therapeutic options for the prevention of stroke. Until recen

Keywords:

Idarucizumab
Antidote
Intensive care medicine
Anesthesia
Intracerebral hemorrhage
Anticoagulant
Dabigatran
Stroke
Medicine
MEDLINE
Diabetes mellitus

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations